HROW Q3 2022 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q3 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$23M+22.0% YoY

Gross Profit

$16M70.6% margin

Operating Income

-$94,000-0.4% margin

Net Income

-$6M-28.3% margin

EPS (Diluted)

$-0.24

QoQ Revenue Growth

-2.1%

Cash Flow

Operating Cash Flow

-$410,000

Free Cash Flow

-$1M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$99M

Total Liabilities

$98M

Stockholders' Equity

$1M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$19M	+22.0%
Gross Profit	$16M	$14M	+17.0%
Operating Income	-$94,000	-$4M	+97.5%
Net Income	-$6M	-$8M	+22.4%

Revenue Segments

Other Revenues

$1M100%